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Abstract
The recent development of platelet concentrate for surgical use is an evolution of the 
fi brin glue technologies used since many years. Fibrin is a biologic glue that compact 
platelet clusters during coagulation process fi brin glues are biologic products that their 
local application has been used to decrease bleeding and accelerate tissue healing in 
the past three decades. Fibrin glue prepared based on a natural biologic mechanism 
(polymerization of fi brin during homeostasis) that reinforced by an artifi cial way. 
However, they were ever criticized because were blood derived products and had a high 
risk of viral infection the production of these products is based on the mixture of two 
plasma components including fi brinogen and thrombin. Platelet-rich plasma (PRP) 
is a fi brin matrix in which platelet cytokines, growth factors, and cells are trapped and 
may be released after a certain time. Choukroun et al. used platelet rich fi brin (PRF) 
protocol in oral and maxillofacial surgery to improve bone healing. Autologous PRF is 
considered to be a healing biomaterial, and presently, studies have shown its application 
in various disciplines of dentistry. PRF is the second generation of platelet concentrates 
which allows fi brin membranes to get enriched with platelets and growth factors, starting 
from an anticoagulant free blood harvest. PRF is similar to a fi brin network that allows 
cell migration and proliferation, and consequently, a more eﬃ  cient cicatrization. Many 
growth factors, such as platelet-derived growth factor and transforming growth factor, are 
released from PRF. One of the major diﬀ erences between PRF and PRP is the diﬀ erent 
polymerization that is responsible for the diﬀ erent biologic properties. PRF released 
autologous growth factors gradually and expressed stronger and more durable eﬀ ect on 
proliferation and diﬀ erentiation, which means that PRF could stimulate the surrounding 
environment to a more rapid wound healing. This review aims to evaluate the eﬀ ect of 
biologic characteristics of fi brin glues, PRP, and PRF.
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Introduction
One of the researchers’ great challenges is to obtain bioactive 
surgical additives to modulate infl ammation and increase healing. 
After each surgical intervention, surgeons confront the complex 
phenomenon of tissue remodeling and the eﬀ ects of it on healing. 
Although the application of fi brin glues was explained more than 
30 years ago,[1,2] because of complex preparation protocol and 
also the risk of cross infection and its usage is still controversial. 
Development of platelet concentrating technique and enhanced 
eﬃ  cacy of protocols lead to produce new fi brin glue were known 
as platelet-rich plasma (PRP) but due to legal limitation for the 
usage of blood products; a new generation of concentrating 
platelets that was nor fi brin glue neither concentrating platelet 
introduced in France. This new product named platelet rich 
fi brin (PRF) was like an autologous cycatrical matrix.
Fibrin
The fi brin is a biologic glue that compact platelet clusters during 
the coagulation process. Fibrinogen is the fi nal production of 
coagulation reaction and it is a soluble protein that by thrombin 
is converted to fi brin. Fibrin polymerized gel is the fi rst matrix 
formed at the wound site.[3,4]
Fibrin and surgical additives
Fibrin glue prepared based on a natural biologic mechanism 
(polymerization of fi brin during homeostasis) that reinforced 
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by an artifi cial way.[5] However, they were ever criticized 
because were blood-derived products. Pharmacologic products 
had a high risk of viral infection, but today simple ways are 
introduced for production of fi brin autologous glues based on 
the development of platelet concentrating technique[6] that these 
products act similarly to the fi nal stage of coagulation cascade 
that fi brinogen converts to fi brin.
Clinical use
Despite signifi cant diﬀ erences between protocols, most of the 
studies showed the high eﬃ  cacy of fi brin glues for controlling 
of slow and widespread bleeding of fi brin parenchyma but 
these products cannot be eﬀ ective for sever vascular bleeding.[2] 
These glues successfully used to stop widespread microvascular 
bleeding and are famous of their ability to seal wound 
borders.[7] Surgeons use the mechanical properties of these 
products in addition to their biologic benefi ts.[8-10] Sealing with 
fi brin glues caused reduction of hematoma before the surgery.[11] 
The usage of fi brin products completely explained for plastic 
and maxillofacial surgery.[7-10] However, many surgeons used 
this glue in diﬀ erent surgeries on animal models and the results 
were contradictory specially for orthopedic and neurosurgery.[12] 
Sealing of dura mater or nerves for reconstruction in trauma or 
tumor surgery was not explained in literature. It showed that 
these products are not more than autologous fi brin glues that 
their major role is only connection of tissues.[12,13]
Concentrated PRP
Due to the risk of hepatitis infection, production of fi brin 
products has been prevented in USA from 1978[14] Hence, the 
combination of concentrated platelet products with the idea 
of cell therapy with growth factors proposed.[14] Concentrated 
platelets were used for prevention and treatment of bleeding 
caused by thrombopenic condition like maxillary aplasia and 
acute leukemia and their usage was limited.[6,15] The production 
protocol of PRR are based on two centrifugation for increased 
platelet aggregation. According to this protocol, the blood 
sample collected before surgery immediately centrifuged to 
concentrated platelets.[16] Then, thrombin and calcium chloride 
added to activate platelets and produced gel.[17-20]
Platelet concentration of plasma is 3-5 times more than 
human plasma.[21] Platelets have a major role on homeostasis 
and are a natural source for growth factors. Activation of 
platelets with diﬀ erent factors like thrombin, calcium chloride 
or collagen causes the release of growth factors. Growth factors 
have a key role on wound healing, regeneration, chemotaxis, 
proliferation, diﬀ erentiation, and angiogenesis.[22] Platelets 
also release factors, such as fi bronectin, vitronectin, and 
sphynosins-1-phosphate, that are eﬀ ective for healing process.
[23] In addition to release of diﬀ erent factors PRR forms a 
fi brin network that acts as a regeneration matrix.[24,25] PRR 
used for soft and hard tissue augmentation, because increases 
vascularization of grafts, improves soft tissue healing, decreases 
the mobility, and increases bone regeneration.[26] Improbable 
cross infection, immunologic reaction is another advantage 
of PRR.[27] PRR makes the handling of grafted material and 
packing of them more easier and increase the maintenance 
of space and bone regeneration potential.[28,29] Since PRR 
contains diﬀ erent growth factors, it stimulates angiogenesis 
and fi broblast diﬀ erentiation. Hence, it recommended for 
improvement of soft tissue healing.[30] Studies showed that PRR 
increases the concentration of grafts and decreases its micron 
scale movement that provides and appropriate environment 
for a successful graft.[31] PRR increases wound maturation and 
epithelialization and decreases scar formation.[32] Epidermal 
growth factor and platelet-derived growth factor are the major 
growth factors responsible for fi broblast migration and collagen 
synthesis. Increased concentration of these growth factors 
are the probable causes of increased wound healing that it 
estimated 2-3 times more than normal situation.[32] In hard 
tissues growth factors aﬀ ect osteoblast. The addition of PRR 
to stromal cells in animal model approved its angiogenic and 
osteogenic properties.[33] Studies showed the successful use of 
PRP for bone regeneration in periodontal defects, extracted 
sockets, implant surgery, and sinus augmentation.[34] One of the 
major challenges of bone augmentation is the prolonged healing 
period, so one of the important indications of PRP is to reduced 
healing period. Shorter time needed for grafts healing in sinus 
augmentation showed in studies.[32,33] Increased regeneration of 
bone in periodontal defects at the distal aspect of 2nd molar after 
surgical removal of 3rd molar had been reported in studies.[34,35] 
But unfortunately, these results were not complete because the 
biopsy cannot be taken from the site. In human studies, use of 
PRR increased bone healing and regeneration.[16,26] Short period 
of improvements of bone regeneration (for 2 weeks) was seen in 
sinus augmentation.[36] Only when target cells like osteoblast and 
osteocyte are present at the site, bone regeneration can occur.[37] 
Because studies used the combination of non-organic grafts with 
PRR did not show any benefi t in diﬀ erent follow-up periods.[36] 
In animal studies when spongy bone of iliac crest used as the 
graft material for sinus lift with PRR the clinical results in case 
and control group was similar.[28,38] One of the results put 
forward the less than expected eﬀ ects of PRR in studies, may be 
that concentration of growth factors in PRR is much less than 
expected eﬀ ects of PRR in studies, may be that concentration of 
growth factors in PRR is much less than the value that has clinical 
eﬀ ects. It seems that the cytokines potential that release during 
the platelet activation and fi brin network formation is extremely 
limited.[39,40] It expected that fi brin network acts as a supportive 
matrix for cytokines, but these soluble molecules release so fast 
that they cannot place into this structure.
PRF
PRF was used for the fi rst time by Choukroun et al.[41] in oral 
and maxillofacial surgery. This technique did not require to 
anticoagulants, thrombin and any other jellying factor and it 
was not anything except a centrifuged blood product without 
any other additives that was not included the laws about the 
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prohibition of blood born products. Only a PC-Q2 centrifuge 
and a kit are needed for PRF production. PRF preparation 
protocol is very easy. The blood samples collected without 
any anticoagulants and immediately centrifuged at 3000 rpm 
for 10 min. Not the usage of anticoagulants causes platelet and 
coagulation cascade as a result of its contact to the wall surface 
within minutes and platelet trapped in the fi brin network. Fibrin 
clot achieved at the middle part tube between red blood cells in 
the bottom and acellular plasma in upper. The success of this 
technique is dependent on the fast collection of blood sample 
and its transfer to the centrifuge. Without use of anticoagulants, 
the sample should be centrifuged within minutes otherwise the 
fi brinogen cannot be concentrated in the middle and upper part 
of tube. It is necessary to concentrate fi brinogen before thrombin 
convert it to fi brin. Hence, the fast preparation of this protocol 
is the key tip to achieve a useful PRF clot. The most important 
property of this technique is not usage of anticoagulants 
that leads to extensive platelet activation and release of large 
amounts of cytokines that these soluble molecules trapped 
into fi brin network.[42] One of the major diﬀ erences between 
PRF and PRR is the diﬀ erent polymerization that is responsible 
for diﬀ erent biologic properties. The addition of thrombin 
and calcium chloride in PRP causes rapid polymerization, 
but PRF polymerization is slow and natural and thrombin 
activity is physiologic. The addition of bone thrombin in PRP 
leads to formation of compacted tetra molecules with bilateral 
connections and thickened polymerizes fi brin that is not 
appropriate for cytokine placement and cell migration. But its 
high strength is suitable for sealing the tissues. Tri molecules 
mono lateral connection formed in PRF due to physiologic 
concentration of thrombin that forms a fl exible network that is 
appropriate for cytokine storage and cell migration and because 
of its fl exibility they are used as membranes.
Conclusion
Platelets contain important growth factors that increase cell 
proliferation, collagen production, chemotaxis, angiogenesis, 
and cell diﬀ erentiation. PRP and PRF are concentrated platelets 
suspension in a small amount of plasma. Moreover, PRP and 
PRF contain three adhesive molecules (fi brin, fi bronectin, 
and vitronectin) that reinforced osteoconduction. The major 
diﬀ erence between these two products is their polymerization 
that leads to their diﬀ erent biologic characteristics. 
Polymerization of PRP is induced by addition of anticoagulants 
but PRF polymerization is a natural and slow process. Hence, 
PRF has more suitable fi brin network for storage of cytokines 
and growth factors and also cell migration.
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